These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 1320179

  • 1. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
    Yasuda H, Sonobe M, Hisanaga T, Kawabata T, Maeda K, Kikkawa R, Shigeta Y.
    Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
    [Abstract] [Full Text] [Related]

  • 2. Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats.
    Sonobe M, Yasuda H, Hisanaga T, Maeda K, Yamashita M, Kawabata T, Kikkawa R, Taniguchi Y, Shigeta Y.
    Diabetes; 1991 Jun; 40(6):726-30. PubMed ID: 1645681
    [Abstract] [Full Text] [Related]

  • 3. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K, Kato N, Matsubara A, Nakano K, Kurono M.
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [Abstract] [Full Text] [Related]

  • 4. Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235.
    Yasuda H, Sonobe M, Yamashita M, Terada M, Hatanaka I, Huitian Z, Shigeta Y.
    Diabetes; 1989 Jul; 38(7):832-8. PubMed ID: 2525492
    [Abstract] [Full Text] [Related]

  • 5. Relation of Na+, K(+)-ATPase to delayed motor nerve conduction velocity: effect of aldose reductase inhibitor, ADN-138, on Na+, K(+)-ATPase activity.
    Hirata Y, Okada K.
    Metabolism; 1990 Jun; 39(6):563-7. PubMed ID: 2161992
    [Abstract] [Full Text] [Related]

  • 6. A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats.
    Yasuda H, Sonobe M, Hatanaka I, Yamashita M, Miyamoto Y, Terada M, Amenomori M, Kikkawa R, Shigeta Y, Motoyama Y.
    Biochem Biophys Res Commun; 1988 Jan 15; 150(1):225-30. PubMed ID: 3276309
    [Abstract] [Full Text] [Related]

  • 7. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
    Raccah D, Coste T, Cameron NE, Dufayet D, Vague P, Hohman TC.
    J Diabetes Complications; 1998 Jan 15; 12(3):154-62. PubMed ID: 9618071
    [Abstract] [Full Text] [Related]

  • 8. Metabolic effect of PGE1 analogue 01206.alpha CD on nerve Na(+)-K(+)-ATPase activity of rats with streptozocin-induced diabetes is mediated via cAMP: possible role of cAMP in diabetic neuropathy.
    Yasuda H, Maeda K, Sonobe M, Kawabata T, Terada M, Hisanaga T, Taniguchi Y, Kikkawa R, Shigeta Y.
    Prostaglandins; 1994 May 15; 47(5):367-78. PubMed ID: 8066185
    [Abstract] [Full Text] [Related]

  • 9. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
    Hirata Y, Fujimori S, Okada K.
    Metabolism; 1988 Feb 15; 37(2):159-63. PubMed ID: 2828821
    [Abstract] [Full Text] [Related]

  • 10. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T, Nishioka H, Yoshioka K, Nakano K, Kondo M, Terashima H.
    Diabetes; 1987 Jan 15; 36(1):6-13. PubMed ID: 3025043
    [Abstract] [Full Text] [Related]

  • 11. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
    Cameron NE, Cotter MA, Robertson S.
    Q J Exp Physiol; 1989 Nov 15; 74(6):917-26. PubMed ID: 2512591
    [Abstract] [Full Text] [Related]

  • 12. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH, Tomlinson DR.
    Diabetologia; 1983 Nov 15; 25(5):433-8. PubMed ID: 6197336
    [Abstract] [Full Text] [Related]

  • 13. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H, Tawata M, Aida K, Onaya T.
    J Clin Endocrinol Metab; 1992 Feb 15; 74(2):393-8. PubMed ID: 1370506
    [Abstract] [Full Text] [Related]

  • 14. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
    Price DE, Airey CM, Alani SM, Wales JK.
    Diabetes; 1988 Jul 15; 37(7):969-73. PubMed ID: 3133261
    [Abstract] [Full Text] [Related]

  • 15. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats.
    Carrington AL, Ettlinger CB, Calcutt NA, Tomlinson DR.
    Diabetologia; 1991 Jun 15; 34(6):397-401. PubMed ID: 1653157
    [Abstract] [Full Text] [Related]

  • 16. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR, Moriarty RJ, Mayer JH.
    Diabetes; 1984 May 15; 33(5):470-6. PubMed ID: 6202576
    [Abstract] [Full Text] [Related]

  • 17. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
    Sredy J, Flam BR, Sawicki DR.
    Proc Soc Exp Biol Med; 1991 Jun 15; 197(2):135-43. PubMed ID: 1851565
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
    Tomlinson DR, Sidenius P, Larsen JR.
    Diabetes; 1986 Apr 15; 35(4):398-402. PubMed ID: 2420664
    [Abstract] [Full Text] [Related]

  • 20. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K.
    Diabetes Res Clin Pract; 1995 Feb 15; 27(2):107-17. PubMed ID: 7607048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.